# STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

> **NCT05785897** · NA · RECRUITING · sponsor: **IGLESIAS Juan Fernando** · enrollment: 350 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction

## Interventions

- **DEVICE:** Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation

## Key facts

- **NCT ID:** NCT05785897
- **Lead sponsor:** IGLESIAS Juan Fernando
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05785897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05785897, "STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05785897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*